AARTI PHARMALABS
Back to Cashflow Statement
|
AARTI PHARMALABS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹262 Cr | ₹330 Cr | ₹216 Cr | ₹250 Cr | ₹-44 Cr |
What is the latest Cash Flow from Operating Activities ratio of AARTI PHARMALABS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹262 Cr |
| Mar2025 | ₹330 Cr |
| Mar2024 | ₹216 Cr |
| Mar2023 | ₹250 Cr |
| Mar2022 | ₹-44 Cr |
How is Cash Flow from Operating Activities of AARTI PHARMALABS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹262 Cr | -20.66 | |
| Mar2025 | ₹330 Cr | 52.59 | |
| Mar2024 | ₹216 Cr | -13.50 | |
| Mar2023 | ₹250 Cr | Positive | |
| Mar2022 | ₹-44 Cr | - | |
Compare Cash Flow from Operating Activities of peers of AARTI PHARMALABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI PHARMALABS | ₹8,026.0 Cr | 5.1% | -5.3% | -2.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,283.0 Cr | 0.9% | -5% | 3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹251,611.0 Cr | 3.6% | -1.4% | 37.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹175,182.0 Cr | 1.7% | -6.7% | 28% | Stock Analytics | |
| CIPLA | ₹109,063.0 Cr | 2.8% | -3.9% | -17.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,926.0 Cr | 5.4% | 8.7% | 1.6% | Stock Analytics | |
AARTI PHARMALABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI PHARMALABS | 5.1% |
-5.3% |
-2.3% |
| SENSEX | -0.3% |
-1.6% |
-12.3% |
You may also like the below Video Courses